During the past decade, Mersin University Medical Faculty conducted 53 clinical trials. In the 10-year time frame, 53 clinical trials started and 17 clinical trials were completed, i.e. on average, 32.1% percent of trials that started reached the finish line to date. In the past 5 years, 31 clinical trials started and 15 clinical trials were completed. i.e. 48.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mersin University Medical Faculty" #1 sponsor was "Celgene" with 6 trials, followed by "Janssen Research & Development, LLC" with 6 trials sponsored, "Eli Lilly and Company" with 5 trials sponsored, "Shire" with 5 trials sponsored and "Hoffmann-La Roche" with 5 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mersin University Medical Faculty" #1 collaborator was "Klinar CRO" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "European Society of Anaesthesiology and Intensive Care" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Mersin University Medical Faculty" are "Crohn's Disease" (10 trials), "Ulcerative Colitis" (7 trials), "Colitis, Ulcerative" (4 trials), "Sickle Cell Disease" (4 trials) and "Crohn Disease" (3 trials). Many other conditions were trialed in "Mersin University Medical Faculty" in a lesser frequency.

Most popular intervention types in "Mersin University Medical Faculty" are "Drug" (50 trials), "Other" (12 trials), "Biological" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (29 trials), "Guselkumab" (5 trials), "Ontamalimab" (4 trials), "Guselkumab Dose 1" (3 trials) and "Guselkumab Dose 2" (3 trials). Other intervention names were less common.

The vast majority of trials in "Mersin University Medical Faculty" are 58 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Mersin University Medical Faculty". undefined are not yet recruiting, 20 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Mersin University Medical Faculty, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Mersin University Medical Faculty, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 45 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".